Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cbd Life Sciences Inc (CBDL)

Cbd Life Sciences Inc (CBDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0003 +33.33%
on 12/20/24
0.0007 -42.86%
on 12/18/24
-0.0002 (-33.33%)
since 11/20/24
3-Month
0.0003 +33.33%
on 12/20/24
0.0022 -81.82%
on 10/28/24
-0.0003 (-42.86%)
since 09/20/24
52-Week
0.0003 +33.33%
on 12/20/24
0.0300 -98.67%
on 04/19/24
-0.0296 (-98.67%)
since 12/15/23

Most Recent Stories

More News
CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization

Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly.

CBDL : 0.0004 (-20.00%)
CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas

Target Acquisition Valued at $10 Million with Projected 2025 Gross Revenue of $5 Million, Positioning CBDL for Explosive Growth in Nevada's Burgeoning Cannabis Market

CBDL : 0.0004 (-20.00%)
CBD Life Sciences, Inc. (CBDL) Reports Stunning 622% Revenue Growth From June to November 2024

Exploding with momentum: CBDL shatters records with 622% revenue growth in five months, propelling to a 1,405% year-to-date increase-a game-changer in the CBD industry.

CBDL : 0.0004 (-20.00%)
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s

Targeting a booming $6 billion U.S. edibles market with a projected $3 million in first-year revenue, CBDL delivers an innovative solution for Alzheimer's care.

CBDL : 0.0004 (-20.00%)
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary

With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.

CBDL : 0.0004 (-20.00%)
CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling

The global cannabis market size was valued at USD 43.72 billion in 2022 and is projected to grow from USD 57.18 billion in 2023 to USD 444.34 billion by 2030, exhibiting a CAGR of 34.03% during the forecast...

CBDL : 0.0004 (-20.00%)
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push

CBDL : 0.0004 (-20.00%)
CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement

CBD Life Sciences propels its expansion with a major MOU, positioning the company for multi-million-dollar growth in the booming $14.6 billion adaptogens market.

CBDL : 0.0004 (-20.00%)
CBD Life Sciences, Inc. (CBDL) Announces MOU With New York Dispensary, Poised for Significant Revenue Growth and Shareholder Value

The targeted acquisition is estimated to have a business value of approximately $10 million and projected 2024 gross revenues of up to $4.5 million

CBDL : 0.0004 (-20.00%)
CBD Life Sciences, Inc. (CBDL) Completes Partnership with Arizona's Largest CBD Wholesaler

SCOTTSDALE, AZ / ACCESSWIRE / July 16, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), through its dynamic subsidiary The CBD Vault Inc, is thrilled to announce a transformative partnership with Sunset...

CBDL : 0.0004 (-20.00%)

Key Turning Points

3rd Resistance Point 0.0007
2nd Resistance Point 0.0006
1st Resistance Point 0.0005
Last Price 0.0004
1st Support Level 0.0003
2nd Support Level 0.0002
3rd Support Level 0.0001

See More

52-Week High 0.0300
Fibonacci 61.8% 0.0187
Fibonacci 50% 0.0151
Fibonacci 38.2% 0.0116
Last Price 0.0004
52-Week Low 0.0003

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar